Validation of #SCORE2 in the Iranian #TLGS cohort shows good discrimination (C-index up to 0.80 in women) but underestimates CVD risk.
Recalibration using national data could improve its accuracy and clinical impact. #CVD #PrimaryPrevention link.springer.com/article/10.1...